![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 1516 |
FusionGeneSummary for ALDOA_SLC1A3 |
![]() |
Fusion gene information | Fusion gene name: ALDOA_SLC1A3 | Fusion gene ID: 1516 | Hgene | Tgene | Gene symbol | ALDOA | SLC1A3 | Gene ID | 226 | 6507 |
Gene name | aldolase, fructose-bisphosphate A | solute carrier family 1 member 3 | |
Synonyms | ALDA|GSD12|HEL-S-87p | EA6|EAAT1|GLAST|GLAST1 | |
Cytomap | 16p11.2 | 5p13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | fructose-bisphosphate aldolase Aaldolase A, fructose-bisphosphateepididymis secretory sperm binding protein Li 87pfructose-1,6-bisphosphate triosephosphate-lyaselung cancer antigen NY-LU-1muscle-type aldolase | excitatory amino acid transporter 1GLAST-1sodium-dependent glutamate/aspartate transporter 1solute carrier family 1 (glial high affinity glutamate transporter), member 3 | |
Modification date | 20180522 | 20180519 | |
UniProtAcc | P04075 | P43003 | |
Ensembl transtripts involved in fusion gene | ENST00000338110, ENST00000395248, ENST00000575627, ENST00000566897, ENST00000569545, ENST00000563060, ENST00000412304, ENST00000564546, ENST00000564595, ENST00000569798, ENST00000395240, | ENST00000265113, ENST00000506725, ENST00000381918, | |
Fusion gene scores | * DoF score | 17 X 7 X 10=1190 | 10 X 9 X 6=540 |
# samples | 20 | 12 | |
** MAII score | log2(20/1190*10)=-2.57288966842058 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(12/540*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ALDOA [Title/Abstract] AND SLC1A3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ALDOA | GO:0008360 | regulation of cell shape | 9244396 |
Hgene | ALDOA | GO:0030388 | fructose 1,6-bisphosphate metabolic process | 9244396|14766013 |
Tgene | SLC1A3 | GO:0015813 | L-glutamate transmembrane transport | 26690923 |
Tgene | SLC1A3 | GO:0051938 | L-glutamate import | 7521911 |
Tgene | SLC1A3 | GO:0070779 | D-aspartate import across plasma membrane | 7521911 |
Tgene | SLC1A3 | GO:0071805 | potassium ion transmembrane transport | 20477940 |
Tgene | SLC1A3 | GO:0098712 | L-glutamate import across plasma membrane | 26690923 |
Tgene | SLC1A3 | GO:0140009 | L-aspartate import across plasma membrane | 20477940 |
Tgene | SLC1A3 | GO:1902476 | chloride transmembrane transport | 20477940 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LGG | TCGA-DU-5870-01A | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000338110 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000338110 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000338110 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
3UTR-5UTR | ENST00000395248 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
3UTR-intron | ENST00000395248 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
3UTR-intron | ENST00000395248 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-5UTR | ENST00000575627 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000575627 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000575627 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-5UTR | ENST00000566897 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000566897 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000566897 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-5UTR | ENST00000569545 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000569545 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000569545 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-5UTR | ENST00000563060 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000563060 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000563060 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-5UTR | ENST00000412304 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000412304 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000412304 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
3UTR-5UTR | ENST00000564546 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
3UTR-intron | ENST00000564546 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
3UTR-intron | ENST00000564546 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-5UTR | ENST00000564595 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000564595 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
5CDS-intron | ENST00000564595 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-5UTR | ENST00000569798 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000569798 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000569798 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-5UTR | ENST00000395240 | ENST00000265113 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000395240 | ENST00000506725 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
intron-intron | ENST00000395240 | ENST00000381918 | ALDOA | chr16 | 30081734 | + | SLC1A3 | chr5 | 36606541 | + |
Top |
FusionProtFeatures for ALDOA_SLC1A3 |
![]() |
Hgene | Tgene |
ALDOA | SLC1A3 |
Plays a key role in glycolysis and gluconeogenesis. Inaddition, may also function as scaffolding protein (Bysimilarity). {ECO:0000250}. | Sodium-dependent, high-affinity amino acid transporterthat mediates the uptake of L-glutamate and also L-aspartate andD-aspartate (PubMed:7521911, PubMed:8123008, PubMed:20477940,PubMed:26690923, PubMed:28032905, PubMed:28424515). Functions as asymporter that transports one amino acid molecule together withtwo or three Na(+) ions and one proton, in parallel with thecounter-transport of one K(+) ion (PubMed:20477940). MediatesCl(-) flux that is not coupled to amino acid transport; thisavoids the accumulation of negative charges due to aspartate andNa(+) symport (PubMed:20477940). Plays a redundant role in therapid removal of released glutamate from the synaptic cleft, whichis essential for terminating the postsynaptic action of glutamate(By similarity). {ECO:0000250|UniProtKB:P56564,ECO:0000269|PubMed:20477940, ECO:0000269|PubMed:26690923,ECO:0000269|PubMed:28032905, ECO:0000269|PubMed:28424515,ECO:0000269|PubMed:7521911, ECO:0000269|PubMed:8123008}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ALDOA_SLC1A3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ALDOA_SLC1A3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ALDOA | XRN1, FANCA, ATP6V1E1, PLD2, USP15, OSBPL10, EGFR, TRIM63, PSMD4, H2AFX, CACNA1A, HDAC5, PCNA, PSMA3, MYC, ISG15, TERF1, CUL3, CUL4B, CUL2, CDK2, MYOC, AKT1, PGK1, ALDOC, HSPD1, LGALS1, LIG4, HSP90AA1, HSP90AB1, VCAM1, FN1, ATF2, IQCB1, MLH1, VCPKMT, ITGA4, RAD52, ALDOB, ALDOA, BCAT2, GALNT6, PIAS4, CS, TNPO3, ADRB2, HUWE1, FUS, IFNA4, SUZ12, HNRNPA1, ACAA2, ACTN4, ACO2, ADI1, ARHGDIA, ASS1, CFL1, COX4I1, ECHS1, FKBP2, GPD1L, GPX4, HSD17B10, IMPA2, ISYNA1, LMAN1, MAP2K7, MYH7B, PKM, SUMO2, TAGLN, TAGLN2, TKT, TRAP1, ATP5J, CKB, CKMT1B, CKMT1A, CKMT2, DUT, ENO1, FABP5, FH, FKBP7, GAPDH, GLO1, HSPE1, KCNAB2, LDHA, LTA4H, NDUFS4, PGAM2, PREP, SOD2, SUMO4, TALDO1, UMPS, NTRK1, HSPB2, SRPK2, AHSA1, CDK2AP1, NCSTN, NCAPH, VPS18, DRC1, MCM2, CDC73, CDH1, CARM1, DNM1L, SOAT1, SOD1, TRIM25, BRCA1 | SLC1A3 | CUL3, ZDHHC17, LGALS3, TCTN3, TMEM17, PDZK1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ALDOA_SLC1A3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | ALDOA | P04075 | DB01593 | Zinc | Fructose-bisphosphate aldolase A | small molecule | approved|investigational |
Hgene | ALDOA | P04075 | DB11638 | Artenimol | Fructose-bisphosphate aldolase A | small molecule | approved|investigational |
Tgene | SLC1A3 | P43003 | DB00142 | Glutamic Acid | Excitatory amino acid transporter 1 {ECO:0000303|PubMed:16042756, ECO:0000303|PubMed:8647279} | small molecule | approved|nutraceutical |
Top |
RelatedDiseases for ALDOA_SLC1A3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ALDOA | C0272066 | Glycogen Storage Disease XII | 3 | CTD_human;ORPHANET;UNIPROT |
Hgene | ALDOA | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | ALDOA | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | ALDOA | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | ALDOA | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Hgene | ALDOA | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | SLC1A3 | C0036341 | Schizophrenia | 4 | PSYGENET |
Tgene | SLC1A3 | C0004352 | Autistic Disorder | 1 | CTD_human |
Tgene | SLC1A3 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Tgene | SLC1A3 | C0014544 | Epilepsy | 1 | CTD_human;HPO |
Tgene | SLC1A3 | C0178417 | Anhedonia | 1 | PSYGENET |
Tgene | SLC1A3 | C2675211 | EPISODIC ATAXIA, TYPE 6 (disorder) | 1 | CTD_human;ORPHANET;UNIPROT |